FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387582339> ?p ?o ?g. }

• W4387582339 endingPage "117267" @default.
• W4387582339 startingPage "117267" @default.
• W4387582339 abstract "For the treatment of hepatocellular carcinoma (HCC), compound Kushen injection (CKi) is commonly used in combination with transarterial chemoembolization (TACE).Our objective was to evaluate the reporting quality, methodological quality, risk of bias, and certainty of evidence for CKi combined with TACE for the treatment of patients with HCC by conducting systematic reviews (SRs). The purpose of this study was to improve the clinical application of CKis, strengthen clinical decision-making regarding CKis, and inform future research.We used eight databases to systematically search SRs of CKi combined with TACE for HCC through February 21, 2023. The quality of reporting of SRs was evaluated using the 2009 Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, methodological quality using A MeaSurement Tool to Assess systematic Reviews 2, risk of bias using the Risk of Bias in Systematic Review, and certainty of evidence using the Grading of Recommendations Assessment. Finally, the assessment results were visualized by the evidence mapping method. This overview has been registered on PROSPERO with the registration title Compound Kushen injection for hepatocellular carcinoma: An overview of systematic reviews and registration number CRD42022369120.A total of 12 SRs meeting the inclusion criteria were included. In terms of reporting quality, 42% of SRs reported relatively complete reports and 58% had certain deficiencies. The methodological quality of all SRs was critically low. The risk of bias was evaluated as low in 33% of SRs and high in 67% of SRs. The results of the evidence synthesis showed that, in the moderate level of evidence, CKi combined with TACE resulted in a 12.7%-21.5% benefit for one-year survival rate, 11.7%-17.2% benefit for objective response rate (ORR), 20.5%-27.1% benefit for quality of life, 22.2% benefit for nausea and vomiting, and 24.7%-27.4% benefit for leukopenia in HCC patients.In conclusion, CKi combined with TACE improved survival, ORR and quality of life in patients with HCC, and reduced adverse events. The results should be interpreted with caution due to the low methodological quality of the included SRs. The clinical efficacy of CKis must be confirmed in a large number of randomized controlled trials." @default.
• W4387582339 created "2023-10-13" @default.
• W4387582339 creator A5001094449 @default.
• W4387582339 creator A5001330715 @default.
• W4387582339 creator A5009387271 @default.
• W4387582339 creator A5012342890 @default.
• W4387582339 creator A5027706413 @default.
• W4387582339 creator A5029136587 @default.
• W4387582339 creator A5032473290 @default.
• W4387582339 creator A5039603911 @default.
• W4387582339 creator A5041015608 @default.
• W4387582339 creator A5059352135 @default.
• W4387582339 creator A5062755510 @default.
• W4387582339 creator A5067567189 @default.
• W4387582339 creator A5078939034 @default.
• W4387582339 creator A5087785658 @default.
• W4387582339 creator A5091359817 @default.
• W4387582339 date "2023-10-01" @default.
• W4387582339 modified "2023-10-16" @default.
• W4387582339 title "Compound Kushen injection combined with transarterial chemoembolization for hepatocellular carcinoma: An evidence map and overview of systematic reviews" @default.
• W4387582339 cites W1889571929 @default.
• W4387582339 cites W1974399531 @default.
• W4387582339 cites W1983478541 @default.
• W4387582339 cites W1992855810 @default.
• W4387582339 cites W1998183252 @default.
• W4387582339 cites W2030840471 @default.
• W4387582339 cites W2046594337 @default.
• W4387582339 cites W2068596545 @default.
• W4387582339 cites W2075950485 @default.
• W4387582339 cites W2091830137 @default.
• W4387582339 cites W2098383911 @default.
• W4387582339 cites W2128985765 @default.
• W4387582339 cites W2129009311 @default.
• W4387582339 cites W2134833483 @default.
• W4387582339 cites W2139248078 @default.
• W4387582339 cites W2167805334 @default.
• W4387582339 cites W2236150109 @default.
• W4387582339 cites W2253148421 @default.
• W4387582339 cites W2332171705 @default.
• W4387582339 cites W2624220637 @default.
• W4387582339 cites W2755585342 @default.
• W4387582339 cites W2756578555 @default.
• W4387582339 cites W2789635905 @default.
• W4387582339 cites W2999536597 @default.
• W4387582339 cites W3012491782 @default.
• W4387582339 cites W3128646645 @default.
• W4387582339 cites W3162961340 @default.
• W4387582339 cites W3184278416 @default.
• W4387582339 cites W3192784738 @default.
• W4387582339 cites W3194040261 @default.
• W4387582339 cites W3195266702 @default.
• W4387582339 cites W3196511436 @default.
• W4387582339 cites W3199839719 @default.
• W4387582339 cites W3203452906 @default.
• W4387582339 cites W4207062361 @default.
• W4387582339 cites W4210779708 @default.
• W4387582339 cites W4225754416 @default.
• W4387582339 cites W4232620598 @default.
• W4387582339 cites W4304689739 @default.
• W4387582339 cites W4306818291 @default.
• W4387582339 cites W4312196649 @default.
• W4387582339 cites W4382343976 @default.
• W4387582339 cites W4384936591 @default.
• W4387582339 doi "https://doi.org/10.1016/j.jep.2023.117267" @default.
• W4387582339 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37838291" @default.
• W4387582339 hasPublicationYear "2023" @default.
• W4387582339 type Work @default.
• W4387582339 citedByCount "0" @default.
• W4387582339 crossrefType "journal-article" @default.
• W4387582339 hasAuthorship W4387582339A5001094449 @default.
• W4387582339 hasAuthorship W4387582339A5001330715 @default.
• W4387582339 hasAuthorship W4387582339A5009387271 @default.
• W4387582339 hasAuthorship W4387582339A5012342890 @default.
• W4387582339 hasAuthorship W4387582339A5027706413 @default.
• W4387582339 hasAuthorship W4387582339A5029136587 @default.
• W4387582339 hasAuthorship W4387582339A5032473290 @default.
• W4387582339 hasAuthorship W4387582339A5039603911 @default.
• W4387582339 hasAuthorship W4387582339A5041015608 @default.
• W4387582339 hasAuthorship W4387582339A5059352135 @default.
• W4387582339 hasAuthorship W4387582339A5062755510 @default.
• W4387582339 hasAuthorship W4387582339A5067567189 @default.
• W4387582339 hasAuthorship W4387582339A5078939034 @default.
• W4387582339 hasAuthorship W4387582339A5087785658 @default.
• W4387582339 hasAuthorship W4387582339A5091359817 @default.
• W4387582339 hasConcept C126322002 @default.
• W4387582339 hasConcept C127413603 @default.
• W4387582339 hasConcept C142724271 @default.
• W4387582339 hasConcept C147176958 @default.
• W4387582339 hasConcept C17744445 @default.
• W4387582339 hasConcept C189708586 @default.
• W4387582339 hasConcept C19527891 @default.
• W4387582339 hasConcept C19648533 @default.
• W4387582339 hasConcept C199539241 @default.
• W4387582339 hasConcept C204787440 @default.
• W4387582339 hasConcept C2777286243 @default.
• W4387582339 hasConcept C2778019345 @default.
• W4387582339 hasConcept C2778618615 @default.
• W4387582339 hasConcept C2779473830 @default.

• next